IMMUGEN PHARMACEUTICALS INC has a total of 28 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are QUANTUM GENOMICS, INST PASTEUR DE MONTEVIDEO and SHENZHEN CHIPSCREEN BIOSCIENCE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | China | 3 | |
#5 | Israel | 2 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Travis Craig R | 24 |
#2 | Travis Craig A | 1 |
#3 | Travis Craig | 1 |
Publication | Filing date | Title |
---|---|---|
AU2004202466A1 | Treatment of immune diseases | |
AU2003263895A1 | Contraceptive methods and formulations | |
WO03080043A1 | Topical formulations of resorcinols and cannibinoids and methods of use | |
WO0226224A2 | Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation | |
US6541510B2 | Antiviral methods and compounds | |
US6566560B2 | Resorcinolic compounds | |
AU3910700A | Treatment of immune diseases | |
CN1939917A | Cannabinol derivatives and pharmaceutical use thereof |